Distribution of TLR9 and uptake of CpG in human neutrophils

被引：0
|
作者：
Hedrick, TL [1 ]
Smith, RL [1 ]
King, CS [1 ]
McElearney, ST [1 ]
Saalwachter, AR [1 ]
Rudy, CK [1 ]
Du, KP [1 ]
Pruett, TL [1 ]
Sawyer, RG [1 ]
机构：
[1] Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [1] Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9
    Liu, Jin
    Xu, Congfeng
    Liu, Yi-Ling
    Matsuo, Hanako
    Hsieh, Rebecca Pe-Feng
    Lo, Jeng-Fan
    Tseng, Ping-Hui
    Yuan, Chiun-Jye
    Luo, Yunping
    Xiang, Rong
    Chuang, Tsung-Hsien
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2012, 35 (05) : 443 - 451
  • [2] Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
    Vollmer, Joerg
    Krieg, Arthur M.
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (03) : 195 - 204
  • [3] CpG Oligodeoxynucleotides as TLR9 AgonistsTherapeutic Applications in Cancer
    Yanal M. Murad
    Timothy M. Clay
    BioDrugs, 2009, 23 : 361 - 375
  • [4] Bacterial CpG-DNA licenses TLR9
    Bauer, S
    Wagner, H
    TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS, 2002, 270 : 145 - 154
  • [5] Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
    Hartmann, Gunther
    MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 34
  • [6] Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA
    Pohar, Jelka
    Yamamoto, Chikako
    Fukui, Ryutaro
    Cajnko, Misa-Mojca
    Miyake, Kensuke
    Jerala, Roman
    Bencina, Mojca
    JOURNAL OF IMMUNOLOGY, 2017, 198 (05): : 2093 - 2104
  • [7] TLR9的特性及其介导的TLR9/CpG-DNA免疫信号通路
    桑丽敏
    唐立
    中国微生态学杂志, 2010, 22 (12) : 1143 - 1146+1149
  • [8] Human pharmacologic activity of a new TLR9 agonist antiviral, CPG 10101 (Actilon™)
    McHutchison, JG
    Bacon, BR
    Gordon, SC
    Afdhal, NH
    Jacobson, IM
    Muir, A
    Krieg, AM
    Efler, S
    Al-Adhami, M
    Davis, HL
    Schmalbach, TK
    HEPATOLOGY, 2004, 40 (04) : 697A - 697A
  • [9] CpG Ofigodeoxynudeofides as TLR9 Agonists Therapeutic Applications in Cancer
    Murad, Yanal M.
    Clay, Timothy M.
    BIODRUGS, 2009, 23 (06) : 361 - 375
  • [10] The TLR9 agonist CpG ODN attenuates cardiac hypertrophy
    Yang, L.
    Jiao, J.
    Zhang, J.
    Li, J.
    Tang, X.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 1011 - 1011
12345